Under the agreement, the prices of Ozempic and Wegovy from Novo Nordisk will decline from $1,000 and $1,350 per month, respectively, to $350 when purchased through TrumpRx.

With open enrollment under way and partisan bickering heating up during the government shutdown, Americans have conflicting views about the U.S. health care system. Despite half of consumers giving ...

Executives at Aflac are hoping that strong dental insurance sales will buoy sales of cancer insurance, hospital indemnity insurance and other worksite benefits products.

UnitedHealthcare pays significantly more to providers affiliated with its Optum subsidiary than to independent providers, according to an analysis published in Health Affairs. The study raises ...

Executives at Voya said they are happy Voya pushed up stop-loss prices and imposed tough underwriting standards this year.

With many Americans living with one or more chronic conditions, advanced primary care can help better manage these patient ...

"In some states, such as Nebraska, the premium increase is a startling 300%," Josh Buchness, a vice president at Founder Shield, said.

A group of 25 Senate Democrats, including Minority Leader Chuck Schumer of New York, on Wednesday sent a letter to HHS Secretary Robert F. Kennedy Jr. criticizing the Trump administration over rising ...

The lawsuit, filed in the Delaware Court of Chancery, comes after an ongoing bidding war between the two pharmaceutical giants over Metsera.

Cigna achieved typical stop-loss customer retention levels, in spite of the price increases, and, in the third quarter, the business "performed in line with expectations," Evanko said. Cigna hopes to ...

The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.

Group captives are among the fastest-growing segments of the captive insurance market, expanding options and creating a greater need for advisors to help clients evaluate quality and risk.